Calypte Biomed,Fortsetzung teil 3
High: 1.230
Low: 1.090
Open: 1.190
Change: -0.04
Volume: 2,230,300
Bid: 0.250
Ask: 2.000
Bid/Ask Size: 1,000 / 500
52 Wk High: 1.799
52 Wk Low: 0.012
%Change: -3.6%
Market Cap: N/A
Price/Sales: N/A
EPS: $0.00
P/E Ratio: N/A
Market Data Powered By ComStock
11/06/03 - 1:40 p.m. Eastern -- No Quote Delay.
Last 10 trades
Time Price Volume Exchange Info
13:40:13 1.090 500 OTCBB
13:39:52 1.100 4000 OTCBB
13:39:52 1.090 2500 OTCBB
13:39:52 1.100 500 OTCBB
13:39:51 1.100 2000 OTCBB
13:39:51 1.100 3000 OTCBB
13:39:47 1.100 1000 OTCBB
13:39:47 1.090 1000 OTCBB
13:39:46 1.090 2500 OTCBB
13:39:40 1.090 1000 OTCBB
Last: 1.080
Close: 1.090
High: 1.230
Low: 1.070
Open: 1.190
Change: -0.05
Volume: 3,396,600
Bid: 0.010
Ask: 7.000
Bid/Ask Size: 500 / 500
52 Wk High: 1.799
52 Wk Low: 0.012
%Change: -3.6%
Market Cap: N/A
Price/Sales: N/A
EPS: $0.00
P/E Ratio: N/A
Market Data Powered By ComStock
11/06/03 - 4:06 p.m. Eastern -- No Quote Delay.
Last 10 trades
Time Price Volume Exchange Info
16:05:53 1.080 5500 OTCBB
16:02:18 1.090 4000 OTCBB
16:00:54 1.085 800 OTCBB
16:00:50 1.095 1000 OTCBB
16:00:41 1.085 6400 OTCBB
16:00:32 1.095 5000 OTCBB
15:59:16 1.090 2100 OTCBB at Bid
15:58:44 1.090 4500 OTCBB at Bid
15:58:41 1.090 4200 OTCBB at Bid
15:57:51 1.090 2000 OTCBB
Bevor die nicht zwischen 60 und 70 Euro-cent liegen, denke ich an einen Einstieg überhaupt nicht nach. M.E. sind die den jetzigen Kurs nicht mal annähernd wert. Dies nur so mal am Rande. Wünsche dir und allen anderen Investierten allerdings noch schöne Träume vom fetten Geld. Die Realität sieht allerding wesentlich anders aus und der Kursverlauf scheint mir auch mehr als nur Recht zu geben (auch wenn's dich anscheinend ziemlich fuchst).
Grüße, ZN
Oh nein, es fuchst mich überhaupt nicht! Ganz im Gegenteil! Je weniger Leute drin sind, desto größer ist das Potential der Aktie! Schließlich gibt es für das Unternehmen noch viel zu tun, um noch mehr potentielle Anleger vom eigenen Unternehmen zu überzeugen!
Kann alles sehr schnell in exponentiellem Maße nach oben gehen: Steigt der Kurs, wächst das Interesse, steigt der Bekanntheitsgrad, melden sich institutionelle Anleger, NASDAQ-Relisting etc....!
Jeder soll sich seine eigene Meinung bilden! Ich habe diese schon gebildet und freue mich eines Tages, dass ich meine Meinung recht früh bilden konnte!
http://www.otcbb.com/asp/quotes.asp?Quotes=CYPT
Headlines 11/07/2003 - TABLE: Unconfirmed Earnings Expected Friday, Nov 7 ????
Sehen wir heute Zahlen?
Zur Charttechnik: "Eine Wissenschaft, die vergeblich sucht was Wissen schaft!"
Na wenn jetzt schon die Strichkucker sagen es geht runter, geht es ganz sicher hoch!
Was zum Geier für ne Unterstützung? Die einzige Unterstützung die ich kenne sind Käufer!
Die Aktie ist m.M.n. die beste Anti-Biowaffen-Versicherung.
Freitag 7. November 2003, 13:31 Uhr Milzbrand-Alarm im Großraum Washington
AFP) Zwei Jahre nach den tödlichen Milzbrandbriefen in den USA ist im Großraum Washington erneut Alarm ausgelöst worden. Elf Postämter blieben am Freitag geschlossen, nachdem bei einer Routineuntersuchung in einer Poststation der Marine Spuren des lebensgefährlichen Krankheitserregers entdeckt wurden. Fünf Angestellte wurden vorsorglich mit Antibiotika behandelt. "Die Sicherheit unserer Angestellten und unserer Kunden hat höchste Priorität", hieß es in einer Erklärung des Postdienstes. Deshalb seien die elf Filialen im Großraum Washington vorübergehend geschlossen worden.
Beverly Hills, CA, Nov 07, 2003 (M2 PRESSWIRE via COMTEX) -- Our-Street.com, an Internet-based, public company watchdog, announced today that it has published an open letter to Earvin "Magic" Johnson requesting that he come forth and comment on the status of his contract and his directorship in Calypte Biomedical Corporation (OTC BB: CYPT). The letter can be read at www.our-street.com/featured.htm Our-Street.com published the letter after numerous attempts to contact Mr. Johnson through his Magic Johnson Foundation failed. The letter to Mr. Johnson asks him to comment on the status of his $1,000,000 (One Million) per year cash consulting contract (plus expenses and stock) and also asks him to confirm if he, in fact, has joined Calypte`s Board of Directors as published reports suggested would have happened in October. Calypte previously had announced that Mr. Johnson would be joining the Board at the July meeting of the Board of Directors.
Previously, Our-Street.com announced that it had filed a complaint with the Securities Exchange Commission against Calypte Biomedical Corporation. (OTC BB:CYPT). The complaint alleges possible violations of Sections 10b-5 and 13a, of the Exchange Act and Section 17 of the Securities Act. The complaint can also be read in its entirety on the Our-Street.com web site.
Our-Street.com is an internet based public company watchdog that researches companies and files and publishes reports and complaints with various regulatory agencies. Previously, Our-Street.com`s complaint against Aqua Vie Beverage Corporation (OTC BB: AQVB) was followed by a suspension in trading by the SEC and their complaints against Kingdom Ventures, Inc (OTC BB: KDMV) and Epixtar Corp. (OTC BB: EPXR) were followed by the companies` disclosure of an investigation being initiated by the SEC and FTC respectively.
Note: Our-street.com is not a financial or investment advisor and is not offering stock for sale or giving investment advice. For investment advice contact a non-conflicted registered investment advisor or non-conflicted broker. The best place to get information about a company is from the SEC.
Specific information about Calypte can be gotten by using this link: www.sec.gov/cgi-bin/browse-edgar?company=calypte&CIK=&filenum=&St ate=&SIC =&owner=include&action=getcompany Our-Street.com and/or their associates do not have a position Calypte Biomedical. Our-street.com has not been paid or compensated in any way to conduct the research and file this complaint. Our-Street.com is member supported by subscriptions but members do not choose which companies Our-Street.com selects to profile.
CONTACT: Nick Tracy Enterprises, Ltd Tel: +44 (0)207 900 2080 Fax: +1 425 740 0645 e-mail: info@our-street.com WWW: www.our-street.com
M2 Communications Ltd disclaims all liability for information provided within M2 PressWIRE. Data supplied by named party/parties. Further information on M2 PressWIRE can be obtained at www.presswire.net on the world wide web. Inquiries to info@m2.com.
(C)1994-2003 M2 COMMUNICATIONS LTD
Our-Street.com macht denen jetzt richtig Ärger, haben sich sozusagen eingeschossen auf euren Liebling.
Gr., ZN
Latest Quote
Last: 1.010
High: 1.090
Low: 1.000
Open: 1.080
Change: -0.08
Volume: 760,700
Bid: 0.960
Ask: 1.050
Bid/Ask Size: 2,500 / 500
52 Wk High: 1.799
52 Wk Low: 0.012
%Change: -7.4%
Market Cap: N/A
Price/Sales: N/A
EPS: $0.00
P/E Ratio: N/A
Market Data Powered By ComStock
11/07/03 - 10:16 a.m. Eastern -- No Quote Delay.
Last 10 trades
Time Price Volume Exchange Info
10:16:47 1.010 1800 OTCBB
10:16:47 1.000 5000 OTCBB
10:16:44 1.010 500 OTCBB
10:16:27 1.000 10000 OTCBB
10:16:00 1.000 8200 OTCBB
10:15:57 1.010 2000 OTCBB
10:15:55 1.000 300 OTCBB
10:15:44 1.000 2000 OTCBB at Ask
10:15:44 1.000 3000 OTCBB at Ask
10:15:44 1.010 2000 OTCBB
High: 1.090
Low: 0.990
Open: 1.080
Change: -0.09
Volume: 846,900
Bid: 0.900
Ask: 1.150
Bid/Ask Size: 2,500 / 2,500
52 Wk High: 1.799
52 Wk Low: 0.012
%Change: -8.3%
Market Cap: N/A
Price/Sales: N/A
EPS: $0.00
P/E Ratio: N/A
Market Data Powered By ComStock
11/07/03 - 10:17 a.m. Eastern -- No Quote Delay.
Last 10 trades
Time Price Volume Exchange Info
10:17:55 1.000 1000 OTCBB at Ask
10:17:55 1.000 1000 OTCBB at Ask
10:17:54 0.990 1000 OTCBB
10:17:54 1.000 1000 OTCBB at Ask
10:17:54 1.000 3300 OTCBB at Ask
10:17:53 0.990 800 OTCBB
10:17:53 0.990 200 OTCBB
10:17:49 1.000 1800 OTCBB at Ask
10:17:49 0.990 2500 OTCBB
10:17:48 0.990 1500 OTCBB
10:18:39 1.000 2000 OTCBB
10:17:55 1.000 1000 OTCBB at Ask
10:17:55 1.000 1000 OTCBB at Ask
10:17:54 0.990 1000 OTCBB
10:17:54 1.000 1000 OTCBB at Ask
10:17:54 1.000 3300 OTCBB at Ask
10:17:53 0.990 800 OTCBB
10:17:53 0.990 200 OTCBB
10:17:49 1.000 1800 OTCBB at Ask